3-hydroxyflavone has been researched along with Myocardial Infarction in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Edgley, AJ; Kelly, DJ; Khong, FL; Kompa, AR; McLachlan, G; Nguyen, C; Woodman, OL; Zhang, Y | 1 |
| Gan, S; Ge, X; Li, B; Liu, L; Yu, H; Zhou, H | 1 |
| Arya, DS; Bhatia, J; Garg, S; Kaur, P; Khan, SI; Kumar, M; Malhotra, RK; Nag, TC; Sharma, MK | 1 |
| Kurian, GA; Rajesh, M; Ravindran, S; Shanmugam, K | 1 |
| Hassaan, PS; Issa, Y; Nassar, SZ; Zahran, N | 1 |
| Arós, F; Basora, J; Corella, D; de la Torre, R; Estruch, R; Fiol, M; Gómez-Gracia, E; Lamuela-Raventós, RM; Lapetra, J; Martínez, JA; Martínez-González, MA; Medina-Remón, A; Pintó, X; Rimm, EB; Ros, E; Ruiz-Gutiérrez, V; Saez, GT; Salas-Salvadó, J; Serra-Majem, L; Sorlí, JV; Tresserra-Rimbau, A; Vinyoles, E | 1 |
| Kedikaetswe, A; Lim, NR; May, CN; Ng, DC; Thomas, CJ; Woodman, OL; Yeap, YY | 1 |
| Chen, YQ; Fei, K; Wang, LX; Wang, S; Xu, YW | 1 |
| Darby, IA; Lee, MW; Limengka, Y; May, CN; Ng, DC; Patsikatheodorou, N; Thomas, CJ; Woodman, OL | 1 |
| Albert, CM; Chae, CU; Hu, F; Lin, J; Manson, JE; Rexrode, KM; Rimm, EB; Stampfer, MJ | 1 |
| Hao, YB; Tang, YZ; Tao, R; Zhang, P | 1 |
| Ascherio, A; Katan, MB; Rimm, EB; Stampfer, MJ; Willett, WC | 1 |
| Feskens, EJ; Hertog, MG; Kromhout, D | 1 |
| Albanes, D; Häkkinen, S; Hirvonen, T; Ovaskainen, ML; Pietinen, P; Virtamo, J; Virtanen, M | 1 |
| Han, BJ; Tang, YZ; Wan, BS; Zhou, EF | 1 |
1 trial(s) available for 3-hydroxyflavone and Myocardial Infarction
| Article | Year |
|---|---|
Inverse association between habitual polyphenol intake and incidence of cardiovascular events in the PREDIMED study.
Topics: Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cardiovascular Diseases; Cohort Studies; Diet, Mediterranean; Female; Flavonols; Follow-Up Studies; Humans; Hydroxybenzoates; Incidence; Lignans; Male; Middle Aged; Myocardial Infarction; Nuts; Olive Oil; Plant Oils; Risk Factors; Spain; Stroke | 2014 |
14 other study(ies) available for 3-hydroxyflavone and Myocardial Infarction
| Article | Year |
|---|---|
NP202 treatment improves left ventricular systolic function and attenuates pathological remodelling following chronic myocardial infarction.
Topics: Animals; Caspase 3; Chemokine CCL2; Chronic Disease; Flavonoids; Gene Expression Regulation; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Remodeling | 2022 |
Fisetin Alleviates Atrial Inflammation, Remodeling, and Vulnerability to Atrial Fibrillation after Myocardial Infarction.
Topics: AMP-Activated Protein Kinases; Animals; Atrial Fibrillation; Atrial Remodeling; Disease Models, Animal; Flavonoids; Flavonols; Male; Myocardial Infarction; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad3 Protein; Transcription Factor RelA | 2019 |
The molecular mechanism involved in cardioprotection by the dietary flavonoid fisetin as an agonist of PPAR-γ in a murine model of myocardial infarction.
Topics: Animals; Cardiotonic Agents; Flavonoids; Flavonols; Heart; Humans; Male; MAP Kinase Signaling System; Mice; Molecular Docking Simulation; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; PPAR gamma; Rats, Wistar; Up-Regulation | 2020 |
Fisetin Confers Cardioprotection against Myocardial Ischemia Reperfusion Injury by Suppressing Mitochondrial Oxidative Stress and Mitochondrial Dysfunction and Inhibiting Glycogen Synthase Kinase 3
Topics: Animals; Flavonoids; Flavonols; Glycogen Synthase Kinase 3 beta; Male; Mitochondria; Myocardial Infarction; Myocardial Reperfusion Injury; Oxidative Stress; Rats | 2018 |
Irisin vs. Treadmill Exercise in Post Myocardial Infarction Cardiac Rehabilitation in Rats.
Topics: Animals; Cardiac Rehabilitation; Fibronectins; Flavonols; Humans; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Physical Conditioning, Animal; Rats; Ventricular Remodeling | 2019 |
Evidence that the MEK/ERK but not the PI3K/Akt pathway is required for protection from myocardial ischemia-reperfusion injury by 3',4'-dihydroxyflavonol.
Topics: Animals; Cardiotonic Agents; Chromones; Drug Therapy, Combination; Female; Flavonoids; Flavonols; MAP Kinase Signaling System; Morpholines; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Primary Cell Culture; Prodrugs; Proto-Oncogene Proteins c-akt; Rats; Sheep; Signal Transduction | 2015 |
Dihydroxyflavonol reduces post-infarction left ventricular remodeling by preventing myocyte apoptosis in the non-infarcted zone in goats.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cytochromes c; Echocardiography; fas Receptor; Female; Flavonols; Goats; In Situ Nick-End Labeling; Male; Myocardial Infarction; Myocytes, Cardiac; Random Allocation; Ventricular Remodeling | 2009 |
Cardioprotection from ischaemia-reperfusion injury by a novel flavonol that reduces activation of p38 MAPK.
Topics: Animals; Apoptosis; Cardiotonic Agents; Dose-Response Relationship, Drug; Enzyme Activation; Flavonols; Hemodynamics; Inflammation; Myocardial Infarction; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Reperfusion Injury; Sheep; Time Factors | 2011 |
Dietary intakes of flavonols and flavones and coronary heart disease in US women.
Topics: Adult; Brassica; Coronary Disease; Diet; Female; Flavones; Flavonols; Humans; Kaempferols; Middle Aged; Multivariate Analysis; Myocardial Infarction; Nurses; Proportional Hazards Models; Prospective Studies; Risk; United States | 2007 |
[Effects of methylflavonolamine on TXA2 and PGI2 plasma levels in rabbits with myocardial infarction].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Female; Flavonoids; Flavonols; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Rabbits; Thromboxane B2 | 1993 |
Relation between intake of flavonoids and risk for coronary heart disease in male health professionals.
Topics: Adult; Aged; Diet; Flavonoids; Flavonols; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Risk Factors; Surveys and Questionnaires; United States | 1996 |
Antioxidant flavonols and coronary heart disease risk.
Topics: Aged; Aged, 80 and over; Antioxidants; Coronary Disease; Diet; Flavonoids; Flavonols; Follow-Up Studies; Humans; Male; Mortality; Myocardial Infarction; Risk; Time Factors | 1997 |
Intake of flavonols and flavones and risk of coronary heart disease in male smokers.
Topics: Aged; Antioxidants; beta Carotene; Cohort Studies; Double-Blind Method; Finland; Flavonoids; Flavonols; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Smoking; Vitamin E | 2001 |
[The effect of 4'-methyl-7-(2-hydroxy-3-isopropylamino-propoxy)-flavone hydrochloride (SIPI-549) on coronary blood flow and experimental myocardial infarction in rabbits].
Topics: Animals; Blood Flow Velocity; Coronary Circulation; Dogs; Flavonoids; Flavonols; In Vitro Techniques; Mice; Myocardial Infarction; Rabbits | 1986 |